Editor Profile

Richard T. Ellison III, MD


About the NEJM Journal Watch Infectious Diseases Board

Richard T. Ellison III, MD, is Professor of Medicine, Microbiology, and Physiological Systems in the Division of Infectious Diseases and Immunology at the University of Massachusetts Medical School, Worcester. His research interests include nosocomial infections, HIV disease, infection control, and control and treatment of infections caused by antibiotic-resistant bacteria. He has pursued basic investigations into innate host defenses against bacterial pathogens and into novel antimicrobial agents active against antibiotic-resistant bacteria. A hospital epidemiologist, Dr. Ellison has focused his investigations on treating hospital-acquired infections and HIV disease. He is a past president of the Massachusetts Infectious Diseases Society. He has written for NEJM Journal Watch Infectious Diseases and served as Deputy Editor from the publication’s launch in 1998 until becoming Editor-in-Chief in 2016.


Consultant / Advisory board

Philips Healthcare

Grant / Research support

Philips Healthcare

  • June 4, 2008

    Improving Sepsis Outcome

    1. Richard T. Ellison III, MD

    A national sepsis-management education program in Spain produced a sustained reduction in hospital mortality among patients with severe sepsis.

  • July 23, 2008

    Building Better Vaccines

    1. Richard T. Ellison III, MD

    The pathogenicity of synthetically generated poliovirus strains can be markedly attenuated by altering the codon pairing within the virus genome.

  • July 30, 2008

    A New Drug Target in MtbFree

    1. Richard T. Ellison III, MD

    In Mycobacterium tuberculosis, a membrane protein is essential for resistance to killing by activated macrophages.

  • September 26, 2007

    Does Thimerosal Affect Neuropsychological Development?Free

    1. Richard T. Ellison III, MD

    No consistent association was found between early childhood exposure to thimerosal-containing vaccines and neuropsychological development.

  • October 24, 2007

    MRSA in the U.S.

    1. Richard T. Ellison III, MD

    Using data from population-based surveillance in nine communities, researchers estimate that MRSA caused 94,360 invasive infections and 18,650 deaths in the U.S. in 2005.

  • October 31, 2007

    Antibiotics for Lyme Encephalopathy?Free

    1. Richard T. Ellison III, MD

    In a randomized, controlled trial, ceftriaxone produced no sustained benefit.